产品中心
-
产品货号
产品名称
规格
销售价
会员价
货期
产地
订购
-
CH17
Recombinant Human Bowman-Birk type proteinase inhibitor/BBI
10ug
1200
1080
现货
国产
-
CH17
Recombinant Human Bowman-Birk type proteinase inhibitor/BBI
50ug
3520
3168
现货
国产
-
CH17
Recombinant Human Bowman-Birk type proteinase inhibitor/BBI
500ug
13440
12096
现货
国产
-
CH17
Recombinant Human Bowman-Birk type proteinase inhibitor/BBI
1mg
19200
17280
现货
国产
- 产品简介
- 使用说明
- 相关产品
- 参考文献
- 购买咨询
Catalog# CH17 Source E. coli Description Recombinant Soybean Birkproteinase inhibitor/BBI is produced with our E. coli expression system. The target protein is expressed with sequence (Asp40-Asn110) of Soybean Birkproteinase inhibitor fused with a 6His tag at the C-terminus. Names Bowman-Birk type proteinase inhibitor is also known as BBI Accession # P01055 Formulation Lyophilized from a 0.2 μM filtered solution of PBS，pH 7.4 Shipping The product is shipped at ambient temperature. Reconstitution Always centrifuge tubes before opening. Do not mix by vortex or pipetting.
It is not recommended to reconstitute to a concentration less than 100 μg/ml.
Dissolve the lyophilized protein in 1X PBS.
Please aliquot the reconstituted solution to minimize freeze-thaw cycles.Storage Lyophilized protein should be stored at < -20°C, though stable at room temperature for 3 weeks.
Reconstituted protein solution can be stored at 4-7°C for 2-7 days.
Aliquots of reconstituted samples are stable at < -20°C for 3 months.Purity Greater than 95% as determined by SEC-HPLC and reducing SDS-PAGE. Endotoxin Less than 0.1 ng/µg (1 IEU/µg). Amino Acid Sequence MDDESSKPCCDQCACTKSNPPQCRCSDMRLNSCHSACKSCICALSYPAQCFCVDITDFCYEPCKP SEDDKENLEHHHHHHBackground Bowman-Birk type proteinase inhibitor is also known as BBI. In molecular biology, Bowman–Birk protease inhibitor family of proteins consist of eukaryotic proteinase inhibitors, belonging to MEROPS inhibitor family I12, clan IF. They mainly inhibit serine peptidases of the S1 family, but also inhibit S3 peptidases. Proteins of the Bowman–Birk inhibitor family of serine proteinase inhibitors interact with the enzymes they inhibit via an exposed surface loop that adopts the canonical proteinase inhibitory conformation. The resulting noncovalent complex renders the proteinase inactive.